RT Journal Article
SR Electronic
T1 Modelling the impact of travel restrictions on COVID-19 cases in Newfoundland and Labrador
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.02.20186874
DO 10.1101/2020.09.02.20186874
A1 Hurford, Amy
A1 Rahman, Proton
A1 Concepción Loredo-Osti, J.
YR 2021
UL http://medrxiv.org/content/early/2021/05/21/2020.09.02.20186874.abstract
AB In many jurisdictions, public health authorities have implemented travel restrictions to reduce coronavirus disease 2019 (COVID-19) spread. Policies that restrict travel within countries have been implemented, but the impact of these restrictions is not well known. On May 4th, 2020, Newfoundland and Labrador (NL) implemented travel restrictions such that non-residents required exemptions to enter the province. We fit a stochastic epidemic model to data describing the number of active COVID-19 cases in NL from March 14th to June 26th. We predicted possible outbreaks over 9 weeks, with and without the travel restrictions, and for contact rates 40% to 70% of pre-pandemic levels. Our results suggest that the travel restrictions reduced the mean number of clinical COVID-19 cases in NL by 92%. Furthermore, without the travel restrictions there is a substantial risk of very large outbreaks. Using epidemic modelling, we show how the NL COVID-19 outbreak could have unfolded had the travel restrictions not been implemented. Both physical distancing and travel restrictions affect the local dynamics of the epidemic. Our modelling shows that the travel restrictions are a plausible reason for the few reported COVID-19 cases in NL after May 4th.Competing Interest StatementAll authors are members of the Predictive Analytics team assembled by the Newfoundland and Labrador Center for Health Information to provide mathematical modelling support to the province of Newfoundland and Labrador. This manuscript arises from a technical report that was prepared at the request of the Department of Justice and Public Safety, Newfoundland and Labrador. This study was not influenced by any representatives of Newfoundland and Labrador.Funding StatementAH was supported by funding from an NSERC Discovery GrantAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study considers only publicly available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code are archived on FigShare. https://doi.org/10.6084/m9.figshare.12906710.v2